These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17182560)

  • 1. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.
    Mulrooney TJ; Zhang AC; Goldgur Y; Boudreau JE; Hsu KC
    J Immunol; 2015 Aug; 195(3):1242-50. PubMed ID: 26109640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
    Gardiner CM; Guethlein LA; Shilling HG; Pando M; Carr WH; Rajalingam R; Vilches C; Parham P
    J Immunol; 2001 Mar; 166(5):2992-3001. PubMed ID: 11207248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
    Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
    Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.
    Morvan M; Willem C; Gagne K; Kerdudou N; David G; Sébille V; Folléa G; Bignon JD; Retière C
    J Immunol; 2009 Jun; 182(11):6727-35. PubMed ID: 19454667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
    Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
    Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1.
    O'Connor GM; Yamada E; Rampersaud A; Thomas R; Carrington M; McVicar DW
    J Immunol; 2011 Sep; 187(5):2162-71. PubMed ID: 21804024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
    Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
    J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection.
    Pascal V; Yamada E; Martin MP; Alter G; Altfeld M; Metcalf JA; Baseler MW; Adelsberger JW; Carrington M; Anderson SK; McVicar DW
    J Immunol; 2007 Aug; 179(3):1625-33. PubMed ID: 17641029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
    Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
    J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
    Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
    PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
    Vyas Y; Selvakumar A; Steffens U; Dupont B
    Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.
    O'Connor GM; Vivian JP; Gostick E; Pymm P; Lafont BA; Price DA; Rossjohn J; Brooks AG; McVicar DW
    J Virol; 2015 May; 89(10):5213-21. PubMed ID: 25740999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.
    Carr WH; Pando MJ; Parham P
    J Immunol; 2005 Oct; 175(8):5222-9. PubMed ID: 16210627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.
    Gillespie GM; Bashirova A; Dong T; McVicar DW; Rowland-Jones SL; Carrington M
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):451-5. PubMed ID: 17411378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
    Martin MP; Qi Y; Gao X; Yamada E; Martin JN; Pereyra F; Colombo S; Brown EE; Shupert WL; Phair J; Goedert JJ; Buchbinder S; Kirk GD; Telenti A; Connors M; O'Brien SJ; Walker BD; Parham P; Deeks SG; McVicar DW; Carrington M
    Nat Genet; 2007 Jun; 39(6):733-40. PubMed ID: 17496894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.
    Boudreau JE; Mulrooney TJ; Le Luduec JB; Barker E; Hsu KC
    J Immunol; 2016 Apr; 196(8):3398-410. PubMed ID: 26962229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
    Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.
    Erer B; Takeuchi M; Ustek D; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Duymaz-Tozkir J; Gül A; Kastner DL; Remmers EF; Ombrello MJ
    Genes Immun; 2016 Dec; 17(7):396-399. PubMed ID: 27708262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.